Flash | 29 Jul 2026 07:24:27 ET │ 11 pages Integra Lifesciences Holdings Corp (IART.O) IART 2Q26 First Look: Despite Strong Quarter, Concerns on Integra Skin CITI'S TAKE IART reported 2Q26 revenue of $418.8M (up 0.7% organic), above FactSet consensus's $417.5M, including Specialty Surgery sales of $309.3M (up 1.6%, versus consensus's $306.0M) and Tissue Reconstruction of $109.5M (down 2.0%, versus $111.5M). Adjusted EBITDA of $78.4M exceeded consensus's $74.0M, translating to EPS of $0.56 (up 24.8% y/y) tha ...